West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems … Read more
West Pharmaceutical Services Inc (WST) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of March 2025: 0.048x
Based on the latest financial reports, West Pharmaceutical Services Inc (WST) has a cash flow conversion efficiency ratio of 0.048x as of March 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($129.40 Million) by net assets ($2.68 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
West Pharmaceutical Services Inc - Cash Flow Conversion Efficiency Trend (1989–2024)
This chart illustrates how West Pharmaceutical Services Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
West Pharmaceutical Services Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of West Pharmaceutical Services Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Evergy, Inc.
NASDAQ:EVRG
|
0.045x |
|
News Corp B
NASDAQ:NWS
|
0.245x |
|
Expeditors International of Washington, Inc.
NASDAQ:EXPD
|
0.150x |
|
China Citic Bank Corp Ltd Class A
SHG:601998
|
0.046x |
|
Tyson Foods Inc
NYSE:TSN
|
-0.010x |
|
Zillow Group Inc Class C
NASDAQ:Z
|
0.022x |
|
Baxter International Inc
NYSE:BAX
|
-0.027x |
|
Gen Digital Inc.
NASDAQ:GEN
|
0.208x |
Annual Cash Flow Conversion Efficiency for West Pharmaceutical Services Inc (1989–2024)
The table below shows the annual cash flow conversion efficiency of West Pharmaceutical Services Inc from 1989 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $2.68 Billion | $653.40 Million | 0.244x | -9.62% |
| 2023-12-31 | $2.88 Billion | $776.50 Million | 0.270x | -0.05% |
| 2022-12-31 | $2.68 Billion | $724.00 Million | 0.270x | +7.83% |
| 2021-12-31 | $2.34 Billion | $584.00 Million | 0.250x | -1.85% |
| 2020-12-31 | $1.85 Billion | $472.50 Million | 0.255x | +9.16% |
| 2019-12-31 | $1.57 Billion | $367.20 Million | 0.233x | +12.93% |
| 2018-12-31 | $1.40 Billion | $288.60 Million | 0.207x | +30.76% |
| 2017-12-31 | $1.67 Billion | $263.30 Million | 0.158x | +7.21% |
| 2016-12-31 | $1.49 Billion | $219.40 Million | 0.147x | -3.03% |
| 2015-12-31 | $1.40 Billion | $212.40 Million | 0.152x | +10.92% |
| 2014-12-31 | $1.33 Billion | $182.90 Million | 0.137x | -43.65% |
| 2013-12-31 | $906.40 Million | $220.50 Million | 0.243x | -5.38% |
| 2012-12-31 | $728.90 Million | $187.40 Million | 0.257x | +28.83% |
| 2011-12-31 | $654.90 Million | $130.70 Million | 0.200x | -9.71% |
| 2010-12-31 | $625.70 Million | $138.30 Million | 0.221x | -7.04% |
| 2009-12-31 | $579.10 Million | $137.70 Million | 0.238x | -14.20% |
| 2008-12-31 | $487.10 Million | $135.00 Million | 0.277x | +5.30% |
| 2007-12-31 | $490.90 Million | $129.20 Million | 0.263x | -23.26% |
| 2006-12-31 | $419.30 Million | $143.80 Million | 0.343x | +35.26% |
| 2005-12-31 | $337.60 Million | $85.60 Million | 0.254x | +10.81% |
| 2004-12-31 | $301.10 Million | $68.90 Million | 0.229x | -14.82% |
| 2003-12-31 | $257.60 Million | $69.20 Million | 0.269x | +0.43% |
| 2002-12-31 | $201.50 Million | $53.90 Million | 0.267x | +44.63% |
| 2001-12-31 | $176.80 Million | $32.70 Million | 0.185x | -21.68% |
| 2000-12-31 | $205.80 Million | $48.60 Million | 0.236x | -21.06% |
| 1999-12-31 | $232.00 Million | $69.40 Million | 0.299x | -2.80% |
| 1998-12-31 | $230.70 Million | $71.00 Million | 0.308x | +26.42% |
| 1997-12-31 | $278.10 Million | $67.70 Million | 0.243x | -3.12% |
| 1996-12-31 | $252.30 Million | $63.40 Million | 0.251x | +38.62% |
| 1995-12-31 | $254.30 Million | $46.10 Million | 0.181x | -16.57% |
| 1994-12-31 | $229.20 Million | $49.80 Million | 0.217x | +12.31% |
| 1993-12-31 | $199.00 Million | $38.50 Million | 0.193x | +1.68% |
| 1992-12-31 | $178.70 Million | $34.00 Million | 0.190x | -30.97% |
| 1991-12-31 | $161.10 Million | $44.40 Million | 0.276x | +43.77% |
| 1990-12-31 | $187.80 Million | $36.00 Million | 0.192x | -15.64% |
| 1989-12-31 | $188.80 Million | $42.90 Million | 0.227x | -- |